Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Statistics

Total Valuation

ASX:NEU has a market cap or net worth of AUD 2.35 billion. The enterprise value is 2.05 billion.

Market Cap	2.35B
Enterprise Value	2.05B

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:NEU has 126.49 million shares outstanding. The number of shares has decreased by -0.98% in one year.

Current Share Class	126.49M
Shares Outstanding	126.49M
Shares Change (YoY)	-0.98%
Shares Change (QoQ)	-1.34%
Owned by Insiders (%)	3.91%
Owned by Institutions (%)	20.84%
Float	109.12M

Valuation Ratios

The trailing PE ratio is 16.19 and the forward PE ratio is 62.98.

PE Ratio	16.19
Forward PE	62.98
PS Ratio	10.74
PB Ratio	7.27
P/TBV Ratio	7.27
P/FCF Ratio	17.08
P/OCF Ratio	17.08
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.14, with an EV/FCF ratio of 14.91.

EV / Earnings	13.76
EV / Sales	9.37
EV / EBITDA	11.14
EV / EBIT	11.14
EV / FCF	14.91

Financial Position

The company has a current ratio of 40.42

Current Ratio	40.42
Quick Ratio	40.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 54.96% and return on invested capital (ROIC) is 42.42%.

Return on Equity (ROE)	54.96%
Return on Assets (ROA)	41.13%
Return on Invested Capital (ROIC)	42.42%
Return on Capital Employed (ROCE)	56.93%
Revenue Per Employee	27.36M
Profits Per Employee	18.63M
Employee Count	8
Asset Turnover	0.78
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:NEU has paid 41.76 million in taxes.

Income Tax	41.76M
Effective Tax Rate	21.88%

Stock Price Statistics

The stock price has increased by +40.02% in the last 52 weeks. The beta is 1.85, so ASX:NEU's price volatility has been higher than the market average.

Beta (5Y)	1.85
52-Week Price Change	+40.02%
50-Day Moving Average	20.46
200-Day Moving Average	15.36
Relative Strength Index (RSI)	34.02
Average Volume (20 Days)	529,989

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:NEU had revenue of AUD 218.86 million and earned 149.06 million in profits. Earnings per share was 1.15.

Revenue	218.86M
Gross Profit	188.88M
Operating Income	184.07M
Pretax Income	190.82M
Net Income	149.06M
EBITDA	184.10M
EBIT	184.07M
Earnings Per Share (EPS)	1.15

Balance Sheet

The company has 299.54 million in cash and n/a in debt, giving a net cash position of 299.54 million or 2.37 per share.

Cash & Cash Equivalents	299.54M
Total Debt	n/a
Net Cash	299.54M
Net Cash Per Share	2.37
Equity (Book Value)	323.27M
Book Value Per Share	2.60
Working Capital	312.32M

Cash Flow

In the last 12 months, operating cash flow was 137.57 million and capital expenditures -12,000, giving a free cash flow of 137.56 million.

Operating Cash Flow	137.57M
Capital Expenditures	-12,000
Free Cash Flow	137.56M
FCF Per Share	1.09

Margins

Gross margin is 86.30%, with operating and profit margins of 84.11% and 68.11%.

Gross Margin	86.30%
Operating Margin	84.11%
Pretax Margin	87.19%
Profit Margin	68.11%
EBITDA Margin	84.12%
EBIT Margin	84.11%
FCF Margin	62.85%

Dividends & Yields

ASX:NEU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.98%
Shareholder Yield	0.98%
Earnings Yield	6.34%
FCF Yield	5.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 21, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 21, 2017
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:NEU has an Altman Z-Score of 136.87 and a Piotroski F-Score of 6.

Altman Z-Score	136.87
Piotroski F-Score	6